Paropakar Maternity and Women's Hospital Report issue

Academic/Hospital

Organization Overview

First Clinical Trial
2018
NCT04083560
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2019

Timeline

NOW
  • Now

Alternative names

Paropakar Matenity and Women's Hospital, Kathmandu, Nepal | Paropakar Maternity and Women's Hospital

Active Ingredients

Drugs in Other Trials (2)

cobalamin (1 trial)

methylcobalamin (1 trial)

Indications

Overview

  • Highest Phase: Phase 0
  • # of Trials: 2
  • # of Trial APIs: 2